Chief Executive Officer
He PhD in Organic Chemistry from the University of Vienna. More than 20 years in R&D management at Sandoz/Novartis; Founded and developed the biotech company Igeneon (cancer immunotherapy). Main responsibilities: Executive Management. Since 2004 he is a non executive director at Shire Pharmaceuticals International Licensing. He joined Aescap from the start in 2005 and serves as the company's managing partner. In addition he serves on the supervisory boards of F-star, i-Optics and Orphazyme.